Free Trial

Enavate Sciences Gp, LLC Top Holdings and 13F Report (2025)

About Enavate Sciences Gp, LLC

Investment Activity

  • Enavate Sciences Gp, LLC has $132.72 million in total holdings as of March 31, 2025.
  • Enavate Sciences Gp, LLC owns shares of 6 different stocks, but just 5 companies or ETFs make up 80% of its holdings.
  • Approximately 26.07% of the portfolio was purchased this quarter.
  • This quarter, Enavate Sciences Gp, LLC has purchased 5 new stocks and bought additional shares in 1 stock.
  • Enavate Sciences Gp, LLC sold shares of 0 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

Immunome
$32,092,564
ZENAS BIOPHARMA INC
$29,714,736
SIONNA THERAPEUTICS INC
$25,920,194
CAMP4 THERAPEUTICS CORP
$15,143,208
UPSTREAM BIO INC
$15,053,382

Largest New Holdings this Quarter

829401108 - SIONNA THERAPEUTICS INC
$25,920,194 Holding

Largest Purchases this Quarter

SIONNA THERAPEUTICS INC
2,478,030 shares (about $25.92M)
Immunome
1,290,322 shares (about $8.68M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofEnavate Sciences Gp, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Immunome, Inc. stock logo
IMNM
Immunome
$32,092,564$8,683,867 37.1%4,768,58324.2%Medical
ZENAS BIOPHARMA INC
$29,714,7360.0%3,761,35922.4%COM
SIONNA THERAPEUTICS INC
$25,920,194$25,920,194 New Holding2,478,03019.5%COM
CAMP4 THERAPEUTICS CORP
$15,143,2080.0%3,785,80211.4%COM
UPSTREAM BIO INC
$15,053,3820.0%2,459,70311.3%COM
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$14,797,4850.0%7,788,15011.1%Medical

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data